solid execut prop result
report adjust ep vs estim beat
driven fluid out-performance revenu margin favor below-the-
line item quarter highlight organ revenu growth
segment margin expans adj ep growth given strong ytd result
gener construct demand environ organ book impact
 refriger order time meaning traction product initi
view reiter top-lin outlook organ achiev
anticip earn upper half tighten adj ep guidanc rang
vs although confid continu execut believ
current valuat ev/ebitda fairli captur oper trajectori
remain cautiou intermediate-term rfe expect maintain perform
es sustain strong oper momentum includ core growth
esg strength off-set expected/transitori ddp slowdown adj
margin expans volume/convers industri product gain
across portfolio book declin although ddp order
inflect given favor respons itma trade show
fluid primari contributor revenu growth increas core sale
follow adj segment margin expand
impress strong volum organ convers
book growth broad-bas particular strength plastic
bio-pharma busi
rfe choppi continu quarter organ sale
book follow modest out-performance adj segment margin
contract lower volum unfavor mix ineffici
dfr volum ramp said recent custom win support stronger
growth outlook product includ autom benefit improv
come quarter
estim given beat confid continu execut lift
ep maintain ep
cost save particuarli rfe accret capit deploy rel
robust pipelin repres viabl upsid lever vs model
bottom line continu believ ceo rich tobin team make
right move drive enhanc competit product across
platform said remain patient bar valuat pullback and/or
confid sustain rfe growth materi margin/return expans
year price histori
dover corp diversifi global
manufactur annual revenu
three oper segment
engin system fluid
analyst certif import disclosur see disclosur
appreci dover signific transform
year shed non-industri asset establish
streamlin multi-industri portfolio believ well
posit long-term growth across es fluid platform
ep upsid driven volum leverag continu
oper improv remain catalyst
suspect medium-term focu organ opportun within core
busi post-api spin although yield like
support share look either organ growth margin
upsid vs our/consensu model get construct rfe
segment largest variabl view
lsd organ growth es fluids-weight near term
solid near-term oper margin expans driven strong
convers es fluid increment restructur action
stronger expect outdoor emv cycl adopt like extend
increas revenu profit contribut wayn acquisit
accret large-scal share repurchas
sustain strength gener industri spend equat higher
anticip organ growth across segment relat
better anticip execut rfe reinvigor top
line stabilizing/improv margin
reacceler share buyback plan complet
slower materi order stability/improv and/or effici
gain refriger
misstep integr and/or overpay futur deal
compani report oppenheim co inc estim
compani report oppenheim co inc estim
quarterli sale profit segment
note tulsa winch report es bear compress report fluid segment contribut estim
compani report oppenheim co inc
sale
sell administr expens
analysi oper
total revenu
segment profit
note tulsa winch report es bear compress report fluid segment contribut estim
